2017
DOI: 10.18632/oncotarget.21779
|View full text |Cite
|
Sign up to set email alerts
|

Multi-omics analyses of red blood cell reveal antioxidation mechanisms associated with hemolytic toxicity of gossypol

Abstract: Gossypol is an antiproliferative drug with limited use due to its hemolytic toxicity. In this study, accelerated hemolysis was observed in the cows treated with gossypol. Comparative metabolomics were used to gain responsive pathways in the red blood cell (RBC) to the treatment, which were crossly validated by parallel iTRAQ-based proteomic analysis and enzyme activity assay. We found that gossypol treatment appeared to considerably activate pentose phosphate pathway (PPP) with an increased key product of ribo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 35 publications
0
5
0
Order By: Relevance
“…164 This compound also induces an accelerated hemolytic toxicity when administered in vivo. 165 The interference with RBPs represents an additional perspective that contributes to defining the broad mechanism of action of gossypol and its preferential intracellular targets at the tissue-specific level.…”
Section: Musashimentioning
confidence: 99%
“…164 This compound also induces an accelerated hemolytic toxicity when administered in vivo. 165 The interference with RBPs represents an additional perspective that contributes to defining the broad mechanism of action of gossypol and its preferential intracellular targets at the tissue-specific level.…”
Section: Musashimentioning
confidence: 99%
“…This enzyme contains in the cytoplasm of cells in the form of a tripeptide -glycine-cysteine-glutamic acid. Cysteine SH-groups are extremely sensitive to the peroxides action [28,29]. Consequently, it is clear that an increase in GR indicates the active involvement of glutathione in reducing cellular damage by free radicals in various pathologies, including TBI [25].…”
Section: Discussionmentioning
confidence: 99%
“…The development of omics technologies and increased generation of high-throughput omics data have inevitably called for powerful systematic means to analyze them in an integrated manner. Omics, a new way for exploring the pathogenesis of human diseases, is categorized into genomics, epigenomics, transcriptomics, and proteomics, and multiple authors have reported about RBCs and OMICs integrations [ 225 , 226 , 227 , 228 ].…”
Section: Extracellular Vesicles Cargomentioning
confidence: 99%